ASCO 2023 – early first-line lung cancer data mined for datopotamab gold

ASCO 2023 – early first-line lung cancer data mined for datopotamab gold

Submitted by admin on June 7, 2023 - 10:02am
Source: 
EP Vantage
News Tags: 
ASCO 2023
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
non-small cell lung cancer
Headline: 
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
snippet: 
The search is on for signals in front-line use, where Daiichi Sankyo and Astrazeneca have already bet big with the Trop2-targeted project.

Do Not Allow Advertisers to Use My Personal information